Mesothelioma News
For Mesothelioma Staging PET/CT Tops PET/MRI |
NUMB Gene May Suppress Mesothelioma |
Mesothelioma Symptoms May Benefit from Tuberculosis Drugs |
European Buildings May Be Safer by 2028 |
Study Lists Factors That Impact Mesothelioma Prognosis |
Predicting Mesothelioma Outcomes with Blood Tests |
Location Can Affect Mesothelioma Risk |
Mesothelioma Rates Steady Despite Declining Asbestos Use |
Can Robotics Make Mesothelioma Surgery Safer? |
UN Group to Debate Asbestos/Mesothelioma Link |
Nanotechnology for Treatment of Mesothelioma Fluid |
Mesothelioma Study: Taconite Link Appears Weak |
Skin Growths May Point to Mesothelioma |
Lawsuits Focus on Mesothelioma Construction Risks |
Australia Braces for “Rash” of Mesothelioma Cases |
Unusual Chemo Side Effects in One Mesothelioma Patient |
Mesothelioma Chemotherapy Tested |
Studies Confirm Success Factors for Mesothelioma Surgery |
New Detection System for Mesothelioma |
Green Tea, Vitamin C, Chemo Fight Mesothelioma ‘Synergistically’ |
New Drug Combo May Fight Mesothelioma |
Drop in Lung Volume Predicts Poor Mesothelioma Outcome |
Iron Range Mesothelioma Patients May Get Answers |
Systemic Chemotherapy Ineffective in Peritoneal Mesothelioma? |
Asbestos Mesothelioma Risk Increased By Other Fibers |
Estrogen May Impact Mesothelioma Prognosis |
Joint Compound Still a Mesothelioma Threat |
Better Quality of Life from Lung-Sparing Mesothelioma Surgery |
“Net of Evidence” Supports Brake Dust/Mesothelioma Link |
Sharp Rise in Mesothelin May Signal Mesothelioma |
Green Tea Component Fights Mesothelioma |
New Prognostic Tools Could Improve Mesothelioma Treatment |
For Some Patients Chemo Cuts Mesothelioma Survival |
EPP No, Chemotherapy Yes, Suggests New Mesothelioma Study |
Challenges and Promises for Mesothelioma Gene Therapy |
Studies Highlight Global Mesothelioma and Asbestos Problem |
Doctors Test New Intra-Pleural Mesothelioma Drug |
Can Chest X-rays Help Prevent Mesothelioma? |
Mesothelioma Study Suggests Iron Makes Asbestos Toxic |
Chicken Virus Key to Experimental Mesothelioma Treatment |
Localized Mesothelioma May Provide Longer Survival |
Biomarker Test Next Step for New Mesothelioma Drug |
Pakistan May Ban Asbestos to Reduce Mesothelioma |
Pleurodesis for Mesothelioma: Hard to Predict Success |
Mesothelioma Researcher to Be Honored for Service to Society |
Orphan Drugs Increase for Mesothelioma |
Mesothelioma Risk Created by Careless Thieves |
Long-Term Mesothelioma Survivor Used Heat and Chemotherapy |
New Program May Predict Mesothelioma Radiotherapy Response |
Town’s Asbestos and Mesothelioma Risk Subject of Study |
New ‘Calculator’ May Help Guide Mesothelioma Treatment |
Mesothelioma Chemotherapy Could Get a Boost from Altered Virus |
Neoadjuvant Chemo Combo May Improve Mesothelioma Survival |
Implantable Catheter May Provide Mesothelioma Symptom Relief |
New Drug May Slow Spread of Mesothelioma |
Mesothelioma Study Could Improve Immunotherapy |
Special Protein May Impact Mesothelioma Outcome |
FDG/PET Best for Mesothelioma Diagnosis and Prognosis |
Heated Chemo in Mesothelioma Challenged by New Study |
New Agents May Enhance Mesothelioma Therapy |
New Radiotherapy Preserves Healthy Lung in Mesothelioma |
New Orphan Drug Approved for Mesothelioma |
Medicinal Plant for Mesothelioma? |
Mesothelioma Study Suggests Trimodal Falls Short |
Australian Electricians Fear Mesothelioma Risk |
Study Demonstrates Mesothelioma Risk from Shipbuilding |
Mesothelioma Study: QOL Impact Not Enough to Deny Surgery |
Could Iron Removal Stave Off Mesothelioma? |
Measles May Help Fight Mesothelioma |
Mesothelioma Diagnosis: SMRP Not the Answer |
Cancer Drug May Improve Long-Term Mesothelioma Survival |
New Criteria May Help Doctors Predict Mesothelioma Survival |
Mesothelioma Staging Guidelines May Need Revisions |
New Biomarker May Detect Mesothelioma Earlier |
Inhibitor May Reduce Mesothelioma Fluid and Prolong Survival |
Mesothelioma Vaccine Enters Phase 2 Testing |
Asbestosis vs. Mesothelioma: Early Exposure May Make the Difference |
Mesothelioma Patients May Be Low in Antioxidants |
Australian Registry Releases First Mesothelioma Report |
New Mesothelioma Test Available Later This Year |
Moles Could Point to Mesothelioma Risk |
Carbon Nanotubes: The Next Mesothelioma Risk? |
T-Cells Can Predict Mesothelioma Treatment Success |
Mesothelioma Now Covered by Zadroga Act |
Implants May Help Mesothelioma Surgery Patients |
Inhaling Mesothelioma Drug Soon Ready for Patient Trials |
New Tools Help Pathologists Make Mesothelioma Diagnosis |
Monoclonal Antibody a ‘Novel Treatment’ for Mesothelioma? |
Mesothelioma Risk High if Raised Near Asbestos |
Mesothelioma Patients Lack Psychosocial Support |
New Chemo Research: Good and Bad News for Mesothelioma |
Cediranib Fails Phase II Mesothelioma Trial |
Plant Compound May Slow Mesothelioma Tumors |
Study Supports CRS/HIPEC for Peritoneal Mesothelioma |
Europe Launches First Mesothelioma Tissue Bank |
New Chemotherapy Approaches for Mesothelioma |
Mesothelioma Rates Higher Near Exposed Asbestos |
Fighting Mesothelioma: Canada Lose a Battle, U.S. Gears for Another |
New Orphan Drug Approved for Mesothelioma |
Ultrasound: A Safer Way to Manage Mesothelioma? |
Second Treatment Effective for Peritoneal Mesothelioma |
Protein May Predict Mesothelioma Treatment Response |
Immunotherapy for Mesothelioma Shows Promise |
Protease Imaging May Track Mesothelioma |
Maryland Asbestos Law: Beginning of a Trend? |
Mesothelioma Study: Quality of Life “Acceptable” with Pneumonectomy |
Perifosine May Offer New Mesothelioma Treatment |
Immunotherapy May Improve Chemotherapy for Mesothelioma |
High Dose Radiation: Viable for Mesothelioma? |
Australian Study Reveals New Mesothelioma Biomarker |
Pleurodesis May Impact Mesothelioma Scan Results |
Mesothelioma Added to 9/11 Compensation Fund |
Advocacy Groups Call for Global Asbestos Ban |
Drug Combo Fails to Improve Mesothelioma Survival |
Orphan Drug Shows Survival Advantage in Mesothelioma |
New Molecule May Aid Mesothelioma Diagnosis |
States Wrestle with Legal Side of Mesothelioma |
Unions Call for Asbestos-Free Australia |
Mesothelioma Risk Depends on Asbestos Fiber Size |
Alaska Lawmakers Allow Asbestos in Gravel |
Finding the Mesothelioma Asbestos Connection |
Effectiveness of Mesothelioma Drug Improved by Other Compounds |
Chemotherapy “Bath” May Stop Mesothelioma Spread |
Australian Court: Asbestos Company Directors Guilty |
Red Wine for Mesothelioma? |
“Encouraging” Mesothelioma Approach Combines Surgery and Light |
Landlord’s Action Puts Tenants at Mesothelioma Risk |
9/11 Committee Recommends Mesothelioma Coverage |
Radiotherapy for Mesothelioma: Experience Counts |
‘Body Clock’ Chemical Could Help Fight Mesothelioma |
Mesothelioma Vaccine Jump Starts Immunity |
Mesothelioma Study Reveals Need to Step Up Pain Control |
Long-Term Mesothelioma Survival Possible with Tri-Modal Approach |
Mesothelioma Still on the Rise in Japan |
Firefly Compound Guides Mesothelioma Treatment |
UK Announces “Landmark” Mesothelioma Ruling |
Leukemia Drug Fails Mesothelioma Trial |
Chemoprevention of Mesothelioma: A Neglected Approach? |
Mesothelioma Death: Asbestos Was Climber’s Greatest Risk |
Australia’s Mesothelioma Fight Comes to Television |
Mesothelioma Clinical Trials Always Recruiting |
MesoMark Falls Short for Early Mesothelioma Diagnosis |
New Trust for Navy Veterans with Mesothelioma |
A New Test for Mesothelioma? |
Spice May Trigger Mesothelioma Cell Breakdown |
New Radiotherapy Technique May be Safer for Mesothelioma |
Railway Employees Lose High Court Mesothelioma Battle |
Is Mesothelioma Hereditary? |
Mesothelioma ‘Triple Treatment’ May Jump Start Killer Cells |
Mesothelioma Surgery Under Fire Again |
Asbestosis and Mesothelioma Rates Remain High in Louisiana |
Italy Verdict May Have Worldwide Mesothelioma Impact |
Proton Therapy – “Clear Advantages” in Treating Mesothelioma |
Mesothelioma May Affect New Generation of Vets |
Harnessing T-Cells to Fight Mesothelioma |
Mesothelioma Alert: Asbestos Imports Rising |
Mesothelioma Risk from Vintage Prefab Homes |
Cell Protein Linked to Mesothelioma Survival |
New Studies Question Radical Mesothelioma Surgery |
Common Cold Virus – Uncommon Mesothelioma Treatment |
Surgery Provides Better Mesothelioma Diagnosis for Some Patients |
Navy Did Not Protect All Veterans from Mesothelioma |
New Mesothelioma Drug Granted Special FDA Status |
Demolition May Raise Mesothelioma Risk |
Vatalanib Not Effective as a ‘Single Agent’ for Mesothelioma |
‘Breast Cancer Gene’ May Impact Mesothelioma Treatment |
New Study Finds EPP Improves Mesothelioma Quality of Life |
New Asbestos Test May Help Protect Against Mesothelioma |
Genes Predict Mesothelioma Treatment Response |
Modest Increase in Mesothelioma Survival from Chemotherapy |
Actor’s Death Highlights Mesothelioma Risk in Australia |
Canada Halts Mining of Mesothelioma-Causing Asbestos |
Mesothelioma Risk in Consumer Products |
Mesothelioma or Lung Cancer? Pleural Fluid May Tell |
New Blood Test May Help Diagnose Mesothelioma Earlier |
Mesothelioma Sometimes Spreads to Unexpected Places |
Later Exposure Lowers Mesothelioma Risk |
Radiotherapy and EPP is a Winning Combo for Some Mesothelioma Patients |
Light Treatment for Mesothelioma May Get Special Status |
Mesothelioma Prognosis Accuracy Improves with PET/CT ‘Delayed Phase’ |
Royals Address Mesothelioma Risk at Home |
Outlook Better for Women with Peritoneal Mesothelioma |
Order May Impact Mesothelioma Drug Availability |
Mesothelioma Radiation ‘Boost’: A Surgical Alternative? |
Cell Proteins May Predict Mesothelioma Prognosis |
Diagnosing Mesothelioma With a Breath Test |
Both Pleural and Peritoneal Mesothelioma Connected to Asbestos |
Studies Highlight Limited Success of Mesothelioma Anti-Angiogenesis Drugs |
Mesothelioma Deaths Still a Mystery among Minnesota Miners |
Korea: Mesothelioma to Rise for Another 30 Years |
Cell Nucleus a “Strong Predictor” of Mesothelioma Survival |
New Mouse Model for Mesothelioma Drug Testing |
Clinical Trials Offer Options for Mesothelioma |
Possible Second-Line Mesothelioma Treatment Fails |
Pricey Mesothelioma Drug May be Best Second-Line Treatment |
Libby Residents Settle Mesothelioma and Asbestos Lawsuits |
New Clues How Asbestos Causes Mesothelioma |
Rare Form of Mesothelioma Appears after Multimodal Treatment |
Mesothelioma Risk Still Exists After 9/11 |
Study Confirms Mesothelioma Danger for Home Renovators |
According to a new study, standard PET/CT beats PET/MRI for diagnosing and staging pleural tumors such as mesothelioma. 
Researchers at Shandong University in China have pinpointed the connection between low levels of the protein NUMB and a poor mesothelioma prognosis 
Unconventional approach helps patient with pleural effusion. 
A British politician says the country should stand behind a new European Parliament report calling for the removal of asbestos from all public buildings by 2028. 
A new Parisian study suggests that simple-to-measure factors such as patient age and the histological subtype of the mesothelioma can be highly accurate prognostic indicators. 
Two separate teams of Japanese researchers are delving into the possibilities of blood serum indicators that could help predict outcomes in patients with malignant pleural mesothelioma. 
People who live close to ancient rock formations called ophiolites are at higher risk of mesothelioma and other asbestos-related diseases. 
Although asbestos use in the United States has been in decline for more than 30 years, the threat of mesothelioma is still very real.
A Chandler, Arizona man is recovering after becoming the second person in the world to undergo robotic surgery for mesothelioma. 
The link between chrysotile asbestos and illnesses such as mesothelioma will be high on the agenda when the sixth UN Rotterdam Convention meets in Geneva, Switzerland in late April. 
A new article on diagnostic advances predicts some good news for mesothelioma patients and their doctors. 
The long-awaited results of the Minnesota Taconite Workers Health Study are in but many questions remain about the link between the iron-based mineral taconite and malignant mesothelioma. 
One of the world’s leading authorities on mesothelioma says the same genetic mutation that predispose certain people to skin cancer may also put them at higher risk of malignant mesothelioma. 
Two recent news stories highlight the fact that construction workers are often at higher risk for mesothelioma 
American environmental officials charged with protecting the public against mesothelioma could take a lesson from Australia. 
Swiss researches are reporting unusual side effects in one patient arising from mesothelioma treatment with the popular chemotherapy drug pemetrexed. 
A clinical trial in Japan is testing the theory that high levels of chemotherapy delivered before other treatments may pave the way for more successful mesothelioma surgery. 
Completeness of surgery, tumor grade, and the use of the chemotherapy drug cisplatin all have an impact on survival after peritoneal mesothelioma surgery and heated intraoperative chemotherapy, according to recent studies. 
A team of biotech scientists in New York have developed an electrochemical process they say can help clinicians detect mesothelioma cells in blood serum. 
Another study has found that the beneficial compounds in green tea may be powerful mesothelioma fighters – especially when combined with other drugs and nutrients. 
A new study finds that the combination of a naturally occurring protein and a drug used to treat multiple myeloma may offer a promising new approach to treating mesothelioma. 
New research suggests that decreases in lung volume may be an indicator of treatment response for patients with mesothelioma. 
People who live in Minnesota’s Iron Range and have contracted malignant mesothelioma may finally get some explanation as to how it happened. 
A new study of peritoneal mesothelioma patients who had cytoreductive surgery and HIPEC states that having systemic chemotherapy either before or after surgery may not have much effect on outcomes. 
A new study suggests that two other types of mineral particles used in industry may increase the risk of mesothelioma, particularly in people who are also exposed to asbestos. 
Researchers may have found one of the reasons for survival differences in men and women with malignant peritoneal mesothelioma. The key may be in their hormones. 
Asbestos containing joint compound can still comprise a threat to construction workers and do-it-yourselfers. 
Mesothelioma patients who undergo pleurectomy/decortication (P/D) may enjoy a better quality of life afterward than those who have extrapleural pneumonectomy (EPP). 
A new report seeks to put an end to the debate over whether or not asbestos-containing brake dust has the potential to cause mesothelioma cancer. 
Another study has confirmed that the biomarker mesothelin may be a valuable warning sign of mesothelioma in asbestos-exposed workers. It may rise sharply in the months preceding the onset of symptoms. 
Another study appears to confirm the idea that a compound found in green tea may be a powerful tool for combatting malignant pleural mesothelioma. 
A pair of cancer researchers from Rome say treatment for malignant pleural mesothelioma could be improved if more clinicians considered the newest prognostic tools in their treatment planning.
Asbestos disease researchers in Australia say chemotherapy at the end of life may be doing some mesothelioma patients more harm than good. 
A pair of thoracic oncologists from Belgium say it’s time to go a step further in the wake of a controversial study on mesothelioma surgery and examine the impact of perioperative chemotherapy. 
A new report suggests that genetic manipulation with modified viruses may be the wave of the future for combating malignant pleural mesothelioma. 
Two new reports highlight the fact that mesothelioma and other asbestos-related diseases are global issues. 
Doctors at Memorial Sloan Kettering Cancer Center in New York have treated the first patient in a new trial that could offer hope to people with malignant mesothelioma and one of its most common complications.
A mesothelioma doctor believes that lives might be saved if people exposed to asbestos in the workplace received annual chest X-rays. 
An Italian study is shedding some light on exactly what makes asbestos so toxic to people and can eventually lead to mesothelioma.
An experimental treatment using a modified bird virus may hold promise for people with advanced malignant mesothelioma. 
Patients with a rare, localized form of pleural mesothelioma may have a better survival outlook than patients with the more common, diffuse variety. 
A company that makes stem cell-focused treatments for cancer has taken an important step closer to testing a promising new mesothelioma drug. 
Pakistan may be on the brink of banning the leading cause of mesothelioma. 
Pleurodesis is a procedure often used to help relieve some of the symptoms of pleural mesothelioma, but there is still no way to predict how effective it will be in any individual patient. 
A researcher whose work led to the development of the only drug approved specifically for the treatment of mesothelioma is being honored by the National Academy of Sciences. 
Rare diseases like mesothelioma are “winning unprecedented attention” from drug manufacturers. 
Thieves in Massachusetts may end up paying with their lives for stealing asbestos covered copper pipes from abandoned buildings. 
A new medical article has some optimitic news for mesothelioma patients - it reports the case of a long-time mesothelioma survivor who was treated with heat therapy. 
Doctors have recently tested a new way to help clinicians plan and predict outcomes for mesothelioma patients who have radiotherapy. 
Researchers will use a $1.2 million National Institutes of Health grant to study the residual effects of asbestos, the mineral that causes mesothelioma, on the town of Ambler, Pennsylvania. 
An NIH study claims to have found a better way to predict treatment response and survival in peritoneal mesothelioma patients. 
An altered form of a virus that typically causes respiratory illness may help boost the effectiveness of chemotherapy for mesothelioma. 
For treatment of malignant pleural mesothelioma prior to surgery, one chemotherapy combination may be better than another. 
An implantable catheter that allows cancer patients to drain their own excess lung fluid at home may improve quality of life for some mesothelioma patients. 
The first trials of a new drug for mesothelioma show it might be able to help slow the progression of the disease in patients with a certain genetic abnormality. 
Scientists have made an important discovery about a component of the immune system that could have an impact on mesothelioma, one of the rarest and most aggressive cancers. 
Mesothelioma patients whose cells express a protein called CD9 are likely to do better and live longer than those who don’t produce this special protein. 
When it comes to diagnosing mesothelioma and predicting patient prognosis, Positron Emission Tomography (PET) using a radioactive tracer may be the most effective imaging modality. 
A procedure that involves washing heated chemotherapy drugs through the open body cavity after mesothelioma surgery may not be as helpful as some mesothelioma experts had hoped. 
Two new studies out of Japan provide encouraging news about improving therapy for mesothelioma. 
A method for targeted delivery of radiotherapy may be safer than conventional radiotherapy for slowing the spread of malignant pleural mesothelioma in patients who have had surgery. 
Patients suffering from malignant pleural mesothelioma now have another drug option to choose from. 
A new study suggests that a plant used for centuries in Indian Ayurvedic medicine may be a powerful weapon in the fight against deadly malignant mesothelioma.
A team of Swiss doctors have added their names to the list mesothelioma experts who believe that the intense trimodal treatment approach including extrapleural pneumonectomy (EPP) is not the best choice for most patients. 
An official from Australia’s largest electricians union says workers should refuse to modify electric meters until the boxes have been inspected for asbestos, the carcinogen that causes mesothelioma. 
A new study out of Italy found a “high incidence of mesothelioma” among men who worked as shipbuilders in the 1940’s, 50’s and 60’s. 
According to a recent study, the risk of reduced quality of life should not be used as an argument against a new surgical technique for peritoneal mesothelioma. 
A new study published in the Journal of Pathology appears to support the iron overload/mesothelioma connection. 
A new mesothelioma clinical trial being conducted at the Mayo Clinic uses an altered version of the measles virus to combat the deadly cancer. 
Soluble mesothelin-related protein (SMRP), a protein found in the blood serum of some people, may not be as effective a biomarker for mesothelioma as it was once thought to be. 
The case of a German man who has lived more than 9 years with malignant mesothelioma is bringing attention to the drug that may have helped him defy the odds. 
A new study suggests that mesothelioma doctors may be at a disadvantage when it comes to accurately assessing how well patients are responding to treatment. 
The International Association for the Study of Lung Cancer (IASLC) says the current strategy for staging malignant pleural mesothelioma may need to be modified. 
Researchers at one of the country’s top cancer centers say they have found an effective way to diagnose mesothelioma earlier. 
A drug based on a naturally-occurring cell growth inhibitor may boost the effectiveness of chemotherapy against mesothelioma fluid buildup. 
The makers of a new cancer vaccine say they have enrolled the first mesothelioma patients in a study that will combine their drug with chemotherapy against this virulent cancer. 
British researchers studying occupational deaths in England and Wales may have found a way to explain why some people exposed to asbestos develop asbestosis while others develop mesothelioma. 
New research suggests that the antioxidant vitamins found in abundance in fruits and vegetable may have a protective effect against malignant pleural mesothelioma.
The first report using data from the newly-established Australian Mesothelioma Registry has been released, and the new is not good – especially for the country’s blue collar workers. 
A mesothelioma test created and validated at Brigham and Women/s Hospital in Boston could be available to the public within the next couple of months. 
A certain kind of skin lesion may offer a way to identify patients at risk for mesothelioma. 
There’s more evidence that carbon nanotubes, cylindrical carbon molecules used in nanotechnology, electronics, optics and other fields, may cause mesothelioma in the same way that asbestos does. 
Mesothelioma patients whose T-cell counts bounce back quickly after a round of chemotherapy have a better chance of survival. 
First responders and others who have contracted malignant mesothelioma because of their exposure to asbestos during the 9/11 attacks in New York are now eligible for government compensation. 
Mesothelioma patients who undergo surgery for their cancer may benefit from new biological implants to reconstruct their chest wall.
Mesothelioma patients may eventually be inhaling their treatment medications instead of receiving them intravenously. 
Pathologists may be able to do a better job of diagnosing mesothelioma in the lab, thanks to a new set of tools released by the International Mesothelioma Interest Group 
A drug currently used to treat colorectal cancer and some types of head and neck cancer may also offer a new way to combat mesothelioma. 
There’s more evidence that exposure to asbestos early in life increases the risk of mesothelioma and a host of other cancers. 
Most newly diagnosed mesothelioma patients need more psychosocial support than they are getting, according to a British sociologist. 
Three new published studies contain a mixed bag of findings on the effectiveness of chemotherapy for mesothelioma. 
Some disappointing news for mesothelioma patients and doctors who had high hopes for the chemotherapy drug cediranib. 
A natural compound found in red onions, tea and the skins of red apples may play a valuable role in the ongoing fight against malignant mesothelioma. 
Another study supports the safety of a new treatment approach for peritoneal mesothelioma that combines cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemoperfusion (HIPEC). 
A hospital in Cambridge, England has opened Europe’s first dedicated mesothelioma tissue bank, an important step forward for doctors and researchers. 
A pair of new studies may help doctors improve the effectiveness of chemotherapy treatment for mesothelioma. 
Disturbing naturally occurring asbestos, whether for farming or building, can significantly raise the risk of mesothelioma and several other cancers. 
Canadian mesothelioma advocates have lost a major battle in their fight against asbestos, while their American counterparts gear up for another battle of their own in Washington. 
A new drug which is a mesothelin-targeting antibody-drug conjugate (ADC) has been granted orphan drug status by the FDA for the treatment of mesothelioma. 
The same technology used by obstetricians to track pregnancies and by cardiologists to find blood clots may also play a valuable role in managing mesothelioma. 
There is some good news from the Wake Forest School of Medicine for patients with peritoneal mesothelioma 
Mesothelioma researchers say a cell protein, know as serum C-Reactive Protein (CRP), may help predict which treatments are effective in patients. 
A growing number of studies have pointed to the value of unconventional treatments like immunotherapy for mesothelioma. 
A chemical that turns certain extracellular enzymes fluorescent may offer an effective, non-invasive method for tracking the progression of malignant pleural mesothelioma. 
The state of Maryland is cracking down on asbestos removal companies that put their workers and the public at risk for mesothelioma by cutting corners. 
Mesothelioma patients who undergo lung removal surgery (pneumonectomy) can still enjoy an acceptable quality of life, in spite of the risks associated with the surgery 
The makers of the anti-cancer drug perifosine say new research suggests the drug may offer a new way to fight malignant mesothelioma. 
A treatment designed to inhibit a cell protein called CTLA-4 may improve the effectiveness of chemotherapy for mesothelioma. 
Radiation therapy may be a better option for mesothelioma than it used to be – especially when it is delivered using advanced targeting technology. 
A large multi-center Australian study has revealed what researchers say could be an important new biomarker for malignant mesothelioma. 
Mesothelioma patients who undergo a procedure called talc pleurodesis (TP) for excess lung fluid may be harder to monitor with FDG-PET/CT scans afterward. 
New Yorkers and first responders at risk of mesothelioma and other cancers because of 9/11 toxic exposures are now in line for compensation if they need it.
A British organization established to support victims of mesothelioma is joining the call for a total ban on the substance that causes it.
Adding the VEGF-inhibitor bevacizumab to a popular chemotherapy combination for mesothelioma does not appear to prolong survival after all. 
Long-term follow-up on a second-line drug for mesothelioma confirms its potential for prolonging survival. 
Scientists at one of the nation’s top cancer centers say they have come up with a new imaging tool that may make it easier to diagnose and monitor mesothelioma. 
Recent changes in the way some states handle mesothelioma cases may eventually have an impact nationwide. 
The head of an Australian Consortium of Trade Unions (ACTU) is calling on the government to protect its citizens against mesothelioma by ridding the country of asbestos by 2030. 
Scientists who study the connection between asbestos fibers and mesothelioma say they now understand what size particles pose the most danger. 
Alaska lawmakers have decided not to let the threat of mesothelioma stand in the way of progress. 
Even though the cause of mesothelioma – exposure to asbestos – is well-known, it is not always easy for a mesothelioma patient to find his or her own ‘asbestos connection’. 
Two new studies suggest that a popular mesothelioma drug becomes more effective when combined with other compounds. 
There is more evidence that washing heated chemotherapy drugs through the open body cavity after mesothelioma surgery may help stop the cancer from spreading. 
After a ten-year legal battle, seven former corporate directors were recently found guilty of lying to employees and the public about mesothelioma compensation. 
Patients battling mesothelioma may want to discuss with their licensed healthcare provider the idea of adding red wine to their treatment strategy. 
A mesothelioma treatment approach that includes light-activated chemicals and a lung-sparing surgery is being called “safe” and “encouraging” by some of the nation’s top mesothelioma researchers. 
Firefighters and first responders at risk of mesothelioma because of 9/11 may finally be getting some help from the federal government. 
When it comes to advanced radiotherapy techniques for mesothelioma, experience counts. 
One of the chemicals responsible for helping establish the body’s circadian rhythms may also help doctors fight mesothelioma. 
Scientists studying a vaccine for mesothelioma have published some of their most important preliminary data in the respected medical journal Lung Cancer. 
Healthcare providers should make pain control a higher priority for their patients with mesothelioma and other lung-related cancers. 
The case of a Peruvian woman treated for mesothelioma in Italy is more evidence that this rare cancer is not only increasingly treatable, but can even be survivable. 
While the rate of mesothelioma continues to slowly decline in the U.S., the virulent asbestos-linked cancer is still on the rise in Japan. 
An oxidative enzyme derived from fireflies may help shed light on a new treatment for mesothelioma. 
Britain’s highest court has issued what is being called a ‘landmark’ ruling for victims of mesothelioma and other industrial diseases. 
An oral leukemia medicine doctor’s had hoped might help certain mesothelioma patients won’t be moving on to the next level of clinical trials. 
A group of researchers in Italy is calling for renewed study of a mesothelioma prevention approach they say has been ignored for too long. 
An Australian mountain climber who made headlines in 2006 by surviving a harrowing experience on Mt. Everest has died of mesothelioma. 
Australia’s ongoing mesothelioma problem will soon be the subject of a two-part television miniseries. 
NCI Clinical Trials Database provides lists of new mesothelioma treatments for patients 
The Mesomark blood test for mesothelioma may miss the mark when it comes to diagnosing mesothelioma in its earliest stages. 
Starting this month, Navy veterans who got mesothelioma by working with certain types of valves and steam control equipment on ships have a new potential source to help pay their medical bills and expenses. 
New diagnostic test for mesothelioma may be on the horizon. 
There’s more evidence that cancer researchers might do well to spice up their mesothelioma clinical trials. 
There’s more evidence that an advanced method for delivering radiotherapy may improve survival for mesothelioma patients after surgery. 
Mesothelioma patients who believe the railway industry is to blame for their disease have lost an important battle in the Supreme Court.
Could mesothelioma pass from parent to child through the genes? 
New mesothelioma research from Harvard University suggests that if one type of immunotherapy is effective against mesothelioma, three types might be even more effective. 
The group that stirred worldwide debate among medical specialists last year with their stance against a radical mesothelioma surgery is taking up the controversial topic once again. 
For Louisiana residents, their risk of mesothelioma and other asbestos-related diseases remains higher than residents of other states. 
Advocates of better protection for workers from mesothelioma and other occupational diseases have won a major court victory. 
A new study suggests that an up-and-coming type of radiotherapy may do more good – with less damage – than the current gold standard radiation treatments for mesothelioma. 
There is mounting evidence that military veterans who served in Iraq or Afghanistan may be at risk for mesothelioma and other serious respiratory issues because of exposure to airborne toxins. 
Cancer researchers in Australia are harnessing the power of disease-fighting T-cells in the ongoing battle with mesothelioma. 
The news that imports of the toxic mineral asbestos are on the rise in the U.S. is prompting outrage from a mesothelioma patient advocacy group.
The mesothelioma death of an elderly English man is more evidence of the danger posed by aging asbestos, especially in the country’s vintage prefab homes.
A protein imbedded in the outer wall of their cells appears to have an impact on survival for mesothelioma patients. 
Calling it “a harmful procedure” a team of Italian surgeons is recommending against a controversial and radical type of surgery for early-stage mesothelioma. 
Researchers at the University of Pennsylvania are fighting malignant mesothelioma with an unexpected tool – the cold virus. 
For patients who can tolerate it, a Japanese research team says an operation to remove part of the chest lining may be the best way to diagnose early malignant pleural mesothelioma .
Navy veterans are among the most common victims of mesothelioma, the most serious disease caused by asbestos exposure. 
The Federal Drug Administration (FDA) has granted orphan drug status to a medication that may help boost the effectiveness of the standard cisplatin/pemetrexed chemotherapy combination for mesothelioma.
Do not take the dangers of asbestos for granted, warns the EPA, which admits to having done exactly that. 
There has been a setback for doctors hoping the drug vatalanib would be a viable alternative to chemotherapy for mesothelioma patients.
A gene most often associated with breast cancer may also play a vital role in the effectiveness of mesothelioma treatment.
New research out of Italy casts another vote in favor of the controversial and radical surgical approach known as extrapleural pneumonectomy (EPP) for treating mesothelioma.
Engineers have developed an automated system that can quickly distinguish asbestos fibers from other particles and help people avoid asbestos related diseases like mesothelioma. 
Researchers have released the results of studies that help explain why some mesothelioma patients respond well to pemetrexed (Alimta) and others do not.
The chemotherapy combination that has become the standard of care for mesothelioma in many parts of the world appears to be making a modest but measurable difference. 
Harold Hopkins, an Australian film actor best known in the U.S. for playing opposite Mel Gibson in Gallipoli has died of mesothelioma. 
A country that was once the world’s top producer of mesothelioma-causing asbestos has stopped production for the first time in 130 years. 
A recent study by a California firm is warning that hundreds of consumer products contain mesothelioma-causing tremolite asbestos.
A team of medical researchers in Japan is testing a new method for using pleural fluid to distinguish mesothelioma from other diseases. 
Investigators in California are evaluating new technology that could eventually help diagnose mesothelioma with a simple blood test. 
Mesothelioma is usually found in the pleural cavity around the lungs, or the peritoneal cavity encasing the abdomen. But several new studies are reminders of the fact that mesothelioma can spread to other areas of the body. 
According to a new study, the later in life a person is exposed to asbestos, the less likely they are to develop mesothelioma, regardless of how long the exposure is. 
Another study has confirmed the value of radiotherapy as an adjuvant treatment for mesothelioma patients who undergo extrapleural pneumonectomy. 
A cutting edge treatment that uses light to kill cancer cells could soon be more widely available for mesothelioma patients. 
More research has confirmed the value of FDG-PET/CT technology for predicting treatment response in mesothelioma – especially when the scan is conducted in two phases.
Asbestos abatement is in the spotlight as Britain’s youngest royal couple prepares a major renovation of the London palace apartment where they plan to live. 
Women with diffuse malignant peritoneal mesothelioma have a better chance of success with surgery and chemotherapy than their male counterparts. 
Mesothelioma patients on certain types of chemotherapy drugs may have easier access to their treatment in the wake of an executive order from President Obama. 
For mesothelioma patients who are not candidates for surgery, new research suggests that an escalated dose of radiotherapy in the right place may help slow the cancer’s progression 
A cell protein devoted to regulating water transport and another related to DNA replication could be important keys to improved mesothelioma prognosis.
Diagnosing mesothelioma may one day be as simple as taking a breath test. 
Italy has one of the highest rates of mesothelioma in the world and according to two new studies, mesothelioma rates are a “suitable indicator” of asbestos exposure for both peritoneal and pleural mesothelioma. 
Two recent mesothelioma studies suggest that anti-angiogenesis drugs may not be as successful as previously hoped in treating mesothelioma.
More bad news for taconite workers along Minnesota’s Canadian border: The number of taconite workers who have died of mesothelioma has risen from 63 to 82 since last year. 
While mesothelioma rates are expected to start declining in the U.S. within the next decade, Korea’s war on against this aggressive cancer may be just getting started. 
A new study from one of the country’s leading cancer centers suggests that the nuclei of mesothelioma cells may hold vital clues for predicting patient survival. 
Mesothelioma is among the most challenging cancers to treat. Increasingly, doctors are taking a multi-modal approach to treatment including surgery and some combination of adjuvant therapies such as chemotherapy, radiation or other, newer modalities. 
Clinical trials are organized formal studies of a new drug or other treatment protocol in human patients. The NIH currently lists 41 active clinical trials for mesothelioma in the U.S. 
There has been some disappointing news for mesothelioma patients who fail to respond to first-line chemotherapy treatment. 
Residents of Libby, Montana who have contracted mesothelioma and other disease from exposure to asbestos will share a $43 million dollar settlement.
A team of Japanese researchers believe they may have found another piece of the puzzle explaining why asbestos causes malignant mesothelioma.
Advanced mesothelioma treatment approaches like multimodal therapy may not only prolong survival in some patients; they may also cause fundamental changes in the way the disease presents itself. 
A decade after the attack on the World Trade Centers, health officials are bracing for latent health effects such as mesothelioma among the tens of thousands of people exposed to toxic dust at the scene. 
An Australian study reconfirms that performing home renovations on homes built before the 1980’s can put a person at increased risk for mesothelioma if proper precautions are not taken.
